%0 Journal Article %A Santosh Ansumali %A Meher K. Prakash %T A Very Flat Peak: Why Standard SEIR Models Miss the Plateau of COVID-19 Infections and How it Can be Corrected %D 2020 %R 10.1101/2020.04.07.20055772 %J medRxiv %P 2020.04.07.20055772 %X Innumerable variants of the susceptible-exposed-infected-recovered (SEIR) model predicted the course of COVID-19 infections for different countries, along with the ‘peaks’ and the subsequent decline of infections. One thing these models could not have predicted prospectively in January or did not adapt to in the following months is that the peak is rather a ‘plateau’ for many countries. For example, USA and UK have been persisting at the same high peak of approximately 30,000 and 5,000 daily new infections respectively, for more than a month. Other countries had shorter plateaus of about 3 weeks (6,400 cases in Spain). We establish that this plateau is not an artifact, and the “persistence number” describing the decline needs an equally important attention as the “reproduction number”. The solution lies in including the specific epidemiological role of asymptomatics and pre-symptomatics in COVID-19 transmission, different from SARS and influenza. We identify the minimal changes that can be made to any SEIR model to capture this plateau while studying seasonal effects, mitigation strategies, or the second wave of infections etc.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding has been receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available on request %U https://www.medrxiv.org/content/medrxiv/early/2020/05/15/2020.04.07.20055772.full.pdf